Prevention of Thrombosis. Results in urologic surgery using lower molecular dextran
Vecsey, D.; Bánkuti, P.
Die Medizinische Welt 25(5): 198-200
1974
ISSN/ISBN: 0025-8512 PMID: 4814062 Document Number: 73359
Document emailed within 1 workday
Related Documents
Sukhanov, A.A.; Sukhanov, V.A. 1976: Use of law molecular weight dextran for prevention of thrombosis in surgical patients (review of the literature) Khirurgiia 1976(10): 133-135Grunebaum, L.; Fricker, J.P.; Wiesel, M.L.; Vergnes, Y.; Kapps, J.; Cazenave, J.P. 1987: Preliminary results of a randomized trial comparing the efficacy of standard heparin with that of fragmine, a low molecular weight heparin, in the prevention of postoperative thrombosis in cancer surgery Journal des Maladies Vasculaires 12 Suppl B: 102-104
Evarts, C.M.; Feil, E.I. 1971: Thromboembolism after elective surgery of the hip. Detection, natural history, prophylaxis, and results with low molecular weight dextran Orthopedic Clinics of North America 2(1): 167-174
Koppenhagen, K.; Tröster, E.; Matthes, M.; Häring, R. 1990: Prevention of thrombosis with low molecular weight heparin as the only substance and/or with DHE: results of clinical studies Langenbecks Archiv für Chirurgie. Supplement Ii Verhandlungen der Deutschen Gesellschaft für Chirurgie. Deutsche Gesellschaft für Chirurgie. Kongress 1990: 1163-1166
Schwarz, B.; Mittelmeier, H. 1988: Initial clinical experiences with low molecular weight heparin in the prevention of thrombosis in orthopedic surgery Aktuelle Traumatologie 18(5): 226-232
Akanmu, A.S.; Nnodu, O.E.; Giwa, S.O.; Salako, L.A.; Akinsete, I.; Adebule, G.T.; Adekoya-Cole, T.O.; Odunubi, O.O. 2004: Efficacy and safety of enoxaparin, a low molecular weight heparin in the prevention of deep vein thrombosis in Nigerian patients after orthopaedic surgery African Journal of Medicine and Medical Sciences 33(4): 335-340
Poser, R.; Hirche, H. 1992: Randomized double-blind study of therapy of sudden deafness. Low molecular weight dextran + naftidrofuryl vs. low molecular weight dextran + placebo Hno 40(10): 396-399
Francis, C.W.; Pellegrini, V.D.; Marder, V.J.; Harris, C.M.; Totterman, S.; Gabriel, K.R.; Baughman, D.J.; Roemer, S.; Burke, J.; Goodman, T.L. 1989: Prevention of venous thrombosis after total hip arthroplasty. Antithrombin III and low-dose heparin compared with dextran 40 Journal of Bone and Joint Surgery. American Volume 71(3): 327-335
Francis, C.W.; Pellegrini, V.D.; Stulberg, B.N.; Miller, M.L.; Totterman, S.; Marder, V.J. 1990: Prevention of venous thrombosis after total knee arthroplasty. Comparison of antithrombin III and low-dose heparin with dextran Journal of Bone and Joint Surgery. American Volume 72(7): 976-982
Verstraete, M. 1976: Prevention of postoperative deep vein thrombosis and pulmonary embolism by low-dose heparin injection or by dextran Semaine des Hopitaux. Therapeutique 52(7-8): 389-394
Simon, S.; Schönné, F.I. 1975: Kinetics of changes in dextran concentration in the blood of rabbits following administration of dextran preparations of various molecular weights Acta Pharmaceutica Hungarica 45(3): 120-127
Wiig, J.N.; Solhaug, J.H.; Bilberg, T.; Bjerkeset, T.; Edwin, B.; Grüner, O.P.; Havig, O.; Holter, O.; Knudsen, G.; Lundblad, R. 1995: Prophylaxis of venographically diagnosed deep vein thrombosis in gastrointestinal surgery. Multicentre trials 20 mg and 40 mg enoxaparin versus dextran European Journal of Surgery 161(9): 663-668
Ragnaud, J.M.; Gin, H.; Tauzin-Fin, P.; Ballanger, P.; Ballanger, R.; Aubertin, J. 1983: Prevention of post-operative infections in urologic surgery. Comparative study of cotrimoxazole and cefazolin Pathologie-Biologie 31(5): 434-437
Javanović, K.; Marenović, T.; Filipović, N.; Krivokapić, B.; Smiljanić, B.; Mancić, D. 1995: Use of a 7.5% NaCl/6% Dextran 70 solution in the prevention of hemodynamic disorders during surgery of abdominal aortic aneurysms Vojnosanitetski Pregled 52(1): 34-38
Jørgensen, L.N.; Wille-Jørgensen, P.A.; Hauch, O. 1994: Prevention of postoperative thrombosis with low-molecular-weight heparins Ugeskrift for Laeger 156(39): 5667-5672
Haas, S. 1995: Combination of low molecular weight heparin and dihydroergotamine for prevention of thrombosis Deutsche Medizinische Wochenschrift 120(14): 503
Forbes, C.D. 1989: Prevention of deep vein thrombosis--use of the low molecular weight heparin enoxaparin British Journal of Clinical Practice 43(11): 396-400
Yang, Z.; Liu, X.; Dai, S.; Liu, K.; Zhang, Y.; Sun, J.; Yin, X. 2010: Effectiveness of low molecular weight heparin for prevention of deep vein thrombosis after total hip arthroplasty Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 24(9): 1058-1061
Uzan, A.; Clairefond, P.; Mardiguian, J.; Trillou, M.; Le Fur, G.; Mestre, M. 1985: Prevention of experimental thrombosis of the coronary artery, in anesthetized dogs, with a low molecular weight heparin, enoxaparine (PK 10169) Annales Pharmaceutiques Francaises 43(6): 539-546
Borris, L.C.; Lassen, M.R.; Jensen, H.P.; Andersen, B.S.; Poulsen, K.A. 1994: Perioperative thrombosis prophylaxis with low molecular weight heparins in elective hip surgery. Clinical and economic considerations International Journal of Clinical Pharmacology and Therapeutics 32(5): 262-268